Hauptseite > Publikationsdatenbank > Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease > print

001     1025963
005     20250204113850.0
024 7 _ |a 10.1093/brain/awae061
|2 doi
024 7 _ |a 0006-8950
|2 ISSN
024 7 _ |a 1460-2156
|2 ISSN
024 7 _ |a 10.34734/FZJ-2024-03241
|2 datacite_doi
024 7 _ |a 38428032
|2 pmid
024 7 _ |a WOS:001206420100001
|2 WOS
037 _ _ |a FZJ-2024-03241
082 _ _ |a 610
100 1 _ |a Pesch, Verena
|0 P:(DE-Juel1)178945
|b 0
245 _ _ |a Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease
260 _ _ |a Oxford
|c 2024
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1721030795_14182
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The pathological misfolding and aggregation of soluble α-synuclein into toxic oligomers and insoluble amyloid fibrils causes Parkinson's disease, a progressive age-related neurodegenerative disease for which there is no cure. HET-s is a soluble fungal protein that can form assembled amyloid fibrils in its prion state. We engineered HET-s(218-298) to form four different fibrillar vaccine candidates, each displaying a specific conformational epitope present on the surface of α-synuclein fibrils. Vaccination with these four vaccine candidates prolonged the survival of immunized TgM83+/- mice challenged with α-synuclein fibrils by 8% when injected into the brain to model brain-first Parkinson's disease or by 21% and 22% when injected into the peritoneum or gut wall, respectively, to model body-first Parkinson's disease. Antibodies from fully immunized mice recognized α-synuclein fibrils and brain homogenates from patients with Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Conformation-specific vaccines that mimic epitopes present only on the surface of pathological fibrils but not on soluble monomers, hold great promise for protection against Parkinson's disease, related synucleinopathies and other amyloidogenic protein misfolding disorders.
536 _ _ |a 5244 - Information Processing in Neuronal Networks (POF4-524)
|0 G:(DE-HGF)POF4-5244
|c POF4-524
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Flores-Fernandez, José Miguel
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Reithofer, Sara
|0 P:(DE-Juel1)185633
|b 2
700 1 _ |a Ma, Liang
|0 P:(DE-Juel1)180536
|b 3
700 1 _ |a Özdüzenciler, Pelin
|0 P:(DE-Juel1)187484
|b 4
700 1 _ |a Busch, Yannick
|0 P:(DE-Juel1)184506
|b 5
700 1 _ |a Sriraman, Aishwarya
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Wang, YongLiang
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Amidian, Sara
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Kroepel, Chiara V M
|0 P:(DE-Juel1)192136
|b 9
700 1 _ |a Müller, Laura
|b 10
700 1 _ |a Lien, Yi
|0 P:(DE-Juel1)179273
|b 11
700 1 _ |a Rudtke, Olivia
|0 P:(DE-Juel1)196961
|b 12
700 1 _ |a Frieg, Benedikt
|b 13
700 1 _ |a Schröder, Gunnar F
|0 P:(DE-Juel1)132018
|b 14
700 1 _ |a Wille, Holger
|0 0000-0001-5102-8706
|b 15
|e Corresponding author
700 1 _ |a Tamgüney, Gültekin
|0 P:(DE-Juel1)177986
|b 16
|e Corresponding author
773 _ _ |a 10.1093/brain/awae061
|g p. awae061
|0 PERI:(DE-600)1474117-9
|n 5
|p 1644-1652
|t Brain
|v 147
|y 2024
|x 0006-8950
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/Invoice_SOA24LT002384.pdf
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/awae061.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/awae061.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/awae061.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/awae061.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/awae061.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/Invoice_SOA24LT002384.gif?subformat=icon
|x icon
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/Invoice_SOA24LT002384.jpg?subformat=icon-1440
|x icon-1440
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/Invoice_SOA24LT002384.jpg?subformat=icon-180
|x icon-180
856 4 _ |u https://juser.fz-juelich.de/record/1025963/files/Invoice_SOA24LT002384.jpg?subformat=icon-640
|x icon-640
909 C O |o oai:juser.fz-juelich.de:1025963
|p openaire
|p open_access
|p OpenAPC
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)185633
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)180536
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)187484
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 9
|6 P:(DE-Juel1)192136
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 14
|6 P:(DE-Juel1)132018
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 16
|6 P:(DE-Juel1)177986
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-524
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Molecular and Cellular Information Processing
|9 G:(DE-HGF)POF4-5244
|x 0
914 1 _ |y 2024
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-12
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRAIN : 2022
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-12
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-12
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b BRAIN : 2022
|d 2024-12-12
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBI-7-20200312
|k IBI-7
|l Strukturbiochemie
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)IBI-7-20200312
980 _ _ |a UNRESTRICTED
980 _ _ |a APC

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21